Research Interest: Pharmacology & Toxicology, Experimental Pharmacology, Toxicology.

Research Interest: Cancer Diagnostics, Cancer Research, Clinical Trials, Ophthalmology, Business, Economic Genetics, Stem Cell Biology, Cell Biology, Translational Cancer Research, Business Ethics, Oncology, Molecular Biology.

Research Interest: Molecular Biology, Immunology (antibodies, vaccines), and Microbiology (viruses, bacteria, and toxins).

Research Interest: Biotechnology, Artificial Intelligence, Neuroscience, Stem Cell Biology, Tissue Engineering, Stem Cell, Regenerative Medicine, Biodegradation.

Research Interest: Drug Delivery, Continuous manufacturing, Dissolutions, Solubility, Cocrystalisation, Hot-Melt Extrusion, Particle Engineering, Medical Implants, Solid-State Analysis, PAT, QbD, Spray Drying, Process Engineering.

Research Interest: Medicinal Chemistry, Medicinal and Pharmaceutical Chemistry.

Research Interest: Design, Synthesis and qualitative SAR of new anticonvulsant agents acting as non-competitive AMPA receptor antagonists (In collaboration with Dr. Li Niu, Chemistry Department, University at Albany, SUNY, Albany NY), Identifications and synthesis of new anti-cancer agents, Design and synthesis of peptidomimetics as protease inhibitors.

Research Interest: Therapeutic relevance of plant-derived compounds in the field of the gastrointestinal pathologies (IBD, cancer, etc.) and on the signal transduction mechanisms involved in their action.Moreover, Toxicological aspects of natural products are also studied.

Mehraliyeva Sevil Jabrayil graduated from the Faculty of Pharmacy of Azerbaijan State Medical Institute named after N.Narimanov in 1989 with honors diploma. was elected to the position and is currently working in this position.

 In 2010, S.J.Mehraliyeva defended her dissertation on the topic "Development of the technology for obtaining medicinal forms from some multicomponent plant assemblies and studying their biopharmaceutical properties", in 2011 she received the diploma of Doctor of Philosophy in Pharmacy, and in 2014 she received the scientific title of associate professor.

 Sevil Mehraliyeva is a member of the "Problem Commission on Pharmacy and Chemistry", 224156-Specialized Council for master's defense in "Pharmaceutical technology". He participated in the congresses held in 2020-2022, including training on Good Clinical Practice and received a certificate. In February 2022, he completed an internship at DAYTAM, Atatürk University of the Republic of Turkey.

Sevil Mehraliyeva made oral presentations at conferences held in the Republics of Azerbaijan, Russia, and Turkey during the period of her scientific research and was awarded certificates.

For the first time, Sevil Mehraliyeva developed immunotropic granules based on various phytocompositions, dental gel with anti-aging effect, anti-aging cream, anti-seborrheic shampoo, microcapsules for the treatment of atherosclerosis, anti-acne niosomal gel technology, and was awarded Azerbaijan and Eurasian patents (2017). -2022).

Since 2020, Mehraliyeva Sevil Jabrail has been working on her doctoral dissertation on the topic "Development of technology for obtaining nano-forms of medicine based on raw materials of natural origin".

According to the subject of his doctoral dissertation, he developed the technology of extraction from deer antlers grown in Azerbaijan for the first time. The technology of obtaining nanocapsules for the treatment of Alzheimer's, nanoemulsion and nanogel for the treatment of osteoporosis on the basis of this extract and the acquisition of an Azerbaijani patent in this field belong to Sevil Mehraliyeva (2021-2024).

In 2023-24, Sevil Mehraliyeva carried out the method of separating the actinide enzyme, which accelerates the digestion process, from the Chinese actinidia fruits grown in Azerbaijan and the microencapsulation of this enzyme.

Sevil Mehraliyeva also performed the technology of separating rutin from Japanese sophora buds and hop cones and preparing phytosomes based on rutin. Based on these phytosomes, the preparation of phytosomal gel with an effective effect in the treatment of periodontitis and the study of quality criteria were performed by Sevil Mehraliyeva (2024).

Research Interests: pharmaceutical technology, phyto- and animal medicinal technology, nanotechnology, nanocosmetology, nano- and micropharmaceutical medicinals, biopolymer technology, new drug delivery systems, including stomatological drug delivery systems.

Research Interest: Systems Pharmacology, Drug Metabolism & Drug Transport, Pharmacokinetics/Pharmacometrics, Pharmacogenomics, Nanomedicine and Chinese Medicine.

Research Interest: Drug Metaboilism, Mass spectrometry, Pharmacokinetics and Pharmacodynamics, Medicine, Pharmacy.

Research Interest: Isolation and structure elucidation of natural products, Search for bioactive compounds, Antifungal, Anticancer and anti-inflammatory phytochemicals from traditional Chinese medicine (TCM) or other ethnic medicine (e.g. Tujia, Miao and so on);Chemical and pharmacological study of Chinese medicine; Quality control study of Chinese medicine.

AP. Ts. Dr. Liew Kai Bin is the head of department of Pharmaceutical Technology and Industry, Faculty of Pharmacy, University of Cyberjaya (UoC). He obtained his Bachelor’s degree in Pharmacy, Master in Science (Pharmaceutical Technology), and Doctor of Philosophy (Pharmaceutical Technology) from Universiti Sains Malaysia (USM). He served as community and industrial pharmacist prior to joining the academia. He has experience in various pharmaceutical related fields including research and development, product development, bioequivalence study, analytical chemistry, regulatory affair and public health pharmacy. He constantly engages in the development of pharmaceutical and traditional medicine industries in the country. Dr Liew is also a registered professional technologist with the Malaysian Board of Technologist.

 Research Interest: Nano formulations, micelle, orally disintegrating tablet, orally disintegrating film, cosmeceuticals, anti-cancer

Research Interest: Discovery and development of novel protein-protein interaction inhibitors of the Tumorigenic process,Spectrum of drug discovery efforts combining computer-aided drug design, lead Generation, SAR design, Organic Synthesis, Biochemical Assays, Cell Culture Assays and Pharmacology.

Research Interest: Effects of different diets, Dietary factors and fatty acids (especially conjugated fatty acids) on health, Especially on the Cancer Risk.